160 related articles for article (PubMed ID: 26713668)
1. Oligoethylenimine-grafted chitosan as enhanced T1 contrast agent for in vivo targeted tumor MRI.
Tong X; Liu M; Zhang K; Cao Y; Dong J; Jiang B; Lu B; Zheng H; Zhang H; Pei R
J Magn Reson Imaging; 2016 Jul; 44(1):23-9. PubMed ID: 26713668
[TBL] [Abstract][Full Text] [Related]
2. Biocleavable Oligolysine-Grafted Poly(disulfide amine)s as Magnetic Resonance Imaging Probes.
Dong J; Liu M; Zhang K; Cao Y; Jiang B; Zu G; Pei R
Bioconjug Chem; 2016 Jan; 27(1):151-8. PubMed ID: 26646753
[TBL] [Abstract][Full Text] [Related]
3. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
4. The synthesis of a D-glucosamine contrast agent, Gd-DTPA-DG, and its application in cancer molecular imaging with MRI.
Zhang W; Chen Y; Guo DJ; Huang ZW; Cai L; He L
Eur J Radiol; 2011 Sep; 79(3):369-74. PubMed ID: 21106316
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Microenvironment Relaxivity-Changeable Gd-Loaded Poly(L-lysine)/Carboxymethyl Chitosan Nanoparticles as Cancer-Recognizable Magnetic Resonance Imaging Contrast Agents.
Jiang D; Zhang X; Yu D; Xiao Y; Wang T; Su Z; Liu Y; Zhang N
J Biomed Nanotechnol; 2017 Mar; 13(3):243-54. PubMed ID: 29381026
[TBL] [Abstract][Full Text] [Related]
6. Chitosan oligosaccharide based Gd-DTPA complex as a potential bimodal magnetic resonance imaging contrast agent.
Huang Y; Cao J; Zhang Q; Lu ZR; Hua MQ; Zhang XY; Gao H
Magn Reson Imaging; 2016 Jan; 34(1):1-7. PubMed ID: 26485295
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of VEGFR-targeted macromolecular MRI contrast agent based on biotin-avidin-specific binding.
Liu Y; Wu X; Sun X; Wang D; Zhong Y; Jiang D; Wang T; Yu D; Zhang N
Int J Nanomedicine; 2017; 12():5039-5052. PubMed ID: 28765707
[TBL] [Abstract][Full Text] [Related]
8. Oligoethylenimine grafted PEGylated poly(aspartic acid) as a macromolecular contrast agent: properties and in vivo studies.
Jiang B; Liu M; Zhang K; Zu G; Dong J; Cao Y; Zhang L; Pei R
J Mater Chem B; 2016 May; 4(19):3324-3330. PubMed ID: 32263267
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q
Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051
[TBL] [Abstract][Full Text] [Related]
10. Functional Hyperbranched Polylysine as Potential Contrast Agent Probes for Magnetic Resonance Imaging.
Zu G; Liu M; Zhang K; Hong S; Dong J; Cao Y; Jiang B; Luo L; Pei R
Biomacromolecules; 2016 Jun; 17(6):2302-8. PubMed ID: 27187578
[TBL] [Abstract][Full Text] [Related]
11. Multi-functional chitosan nanoparticles encapsulating quantum dots and Gd-DTPA as imaging probes for bio-applications.
Tan WB; Zhang Y
J Nanosci Nanotechnol; 2007 Jul; 7(7):2389-93. PubMed ID: 17663257
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice.
Zong Y; Wang X; Goodrich KC; Mohs AM; Parker DL; Lu ZR
Magn Reson Med; 2005 Apr; 53(4):835-42. PubMed ID: 15799038
[TBL] [Abstract][Full Text] [Related]
13. Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents.
Zong Y; Wang X; Jeong EK; Parker DL; Lu ZR
Magn Reson Imaging; 2009 May; 27(4):503-11. PubMed ID: 18814987
[TBL] [Abstract][Full Text] [Related]
14. A novel manganese chelated macromolecular MRI contrast agent based on O-carboxymethyl chitosan derivatives.
Wang X; Xu L; Ren Z; Fan M; Zhang J; Qi H; Xu M
Colloids Surf B Biointerfaces; 2019 Nov; 183():110452. PubMed ID: 31473409
[TBL] [Abstract][Full Text] [Related]
15. Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging.
Ye M; Qian Y; Tang J; Hu H; Sui M; Shen Y
J Control Release; 2013 Aug; 169(3):239-45. PubMed ID: 23403397
[TBL] [Abstract][Full Text] [Related]
16. Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.
Feng Y; Jeong EK; Mohs AM; Emerson L; Lu ZR
Magn Reson Med; 2008 Dec; 60(6):1347-52. PubMed ID: 19025902
[TBL] [Abstract][Full Text] [Related]
17. Gd complexes of diethylenetriaminepentaacetic acid conjugates of low-molecular-weight chitosan oligosaccharide as a new liver-specific MRI contrast agent.
Huang Y; Cao B; Yang X; Zhang Q; Han X; Guo Z
Magn Reson Imaging; 2013 May; 31(4):604-9. PubMed ID: 23102519
[TBL] [Abstract][Full Text] [Related]
18. Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging.
Ding N; Lu Y; Lee RJ; Yang C; Huang L; Liu J; Xiang G
Int J Nanomedicine; 2011; 6():2513-20. PubMed ID: 22072885
[TBL] [Abstract][Full Text] [Related]
19. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
Li Y; Liu G; Lou X; Chen Z; Ma L
Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
[TBL] [Abstract][Full Text] [Related]
20. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
Khantasup K; Saiviroonporn P; Jarussophon S; Chantima W; Dharakul T
MAGMA; 2018 Oct; 31(5):633-644. PubMed ID: 29737435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
